OS Therapies Incorporated

AMEX: OSTX · Healthcare · Biotechnology

PublicHQ Grasonville, MD · Queen Anne'sCIK 0001795091Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 15DQ —GM —SS 28

v0.1 · 35/100 weight · pillars only

↑ market scale, Altman-Z · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$28.8M

Employees

Market cap

$84.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$28.8M-$28.8M2025

Operating income-$28.7M-$28.7M2025

Total assets$6.8M$6.8M2025

Liabilities$11.9M$11.9M2025

Equity-$6.1M-$6.1M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

OS Therapies Incorporated earned -$28.8M in FY2025 net income.

Peers · Healthcare

Adicet Bio, Inc.——Biomea Fusion, Inc.——Definitive Healthcare Corp.53D Cognition Therapeutics, Inc.——

Key facts

CEOPaul A. Romness

SectorHealthcare

IndustryBiotechnology

HeadquartersGrasonville, MD

ExchangeAMEX: OSTX

Employees5

IPO date2024-08-01

Latest filings

8-K2026-07-02 10-Q2026-05-18 8-K2026-04-30 8-K2026-04-02 8-K2026-03-31 10-K2026-03-31 8-K2026-03-06 8-K2026-02-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.